Updated Jul. 16, 2014 at 3:20 p.m.

Josh Hardy, treated with experimental Chimerix drug, is going home

Published: 2014-07-16 14:37:00
Updated: 2014-07-16 15:20:30


Chimerix, the Durham-based drug company working on experimental medicine that could save the life of a seven-year-old Josh Hardy, was granted approval by the U.S. Food and Drug Administration to administer the drug to the boy in March. On Wednesday, his mother said he is doing well and going home.

Aimee Hardy announced the news through her SaveJosh Facebook page, adding the family is returning home to Virginia.

“Glory to GOD! We are going home!!!! Leaving today. After 6 1/2 months, Josh finally gets to be in his house,” Aimee Hardy wrote.

The Facebook post noted that Josh does not need dialysis and he has improved heart function. 

Her full post reads:

"Glory to GOD! We are going home!!!! Leaving today. After 6 1/2 months, Josh finally gets to be in his house.

"His Kidney function has returned and he is free of the need of Dialysis. His heart function is within normal range. His lung function is perfect. His tummy is coming around. He has not had the need of a blood transfusion in a month. And with a lot of hard work his strength will return. He can walk a nice distance holding my hands. And we anticipate the return of his immunity in a few months.

"John 14:13, 14~And I will do whatever you ask in my name, so that the Father may be glorified in the Son. You may ask me for anything in my name, and I will do it.

"GOD has answered our prayers!

"We do not have to be back in Memphis until 7/29. And after that appointment we should only have to come back to St Jude once a month until the one year mark in January.

"Thank you all for your love, support, and prayers.

"Love~ Aimee"

The Back Story

Chimerix was granted approval by the U.S. Food and Drug Administration to administer the drug brincidofovir to the boy for compassionate use after a media campaign that included family appeals on Facebook and a CNN interview.

Josh was treated at St. Jude Children’s Research Hospital in Memphis, Tenn.

The company originally denied the Hardys because allowing brincidofovir to be used in Josh's treatment doing so could slow down the process of getting the drug to the market, they said.

"Being unable to fulfill requests for compassionate use is excruciating, and not a decision any one of us ever wants to have to make," said Kenneth Moch, president and CEO of Chimerix, in a statement. "It is essential that each individual in a health crisis be treated with equal gravity and value, a principle we have upheld by pursuing further clinical study of brincidofovir that will inform its use in adenovirus and other serious DNA viral infections."

Moch later left the company.

Brincidofovir has "the potential to become the first broad-spectrum antiviral for the prevention and treatment of clinically significant infections and diseases caused by DNA viruses," the company said.

Josh was the first patient in a pilot trial of the medicine.

The FDA allows someone with an immediate life-threatening illness to ask for permission to use experimental drugs that have not yet received the agency’s approval. Last year, the FDA approved 974 such requests, according to CNN.

"Our son will die without this drug," Josh's father, Todd, told CNN. "We're begging them to give it to us."

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

page 1
sort order: oldest first | newest first
To immaanoid and imonyx....God does deserve praise, exactly who do you think blessed those good doctors, scientist, etc. with the knowledge, skill and willpower to help invent such drugs. God works through medicine, doctors, nurses, scientist and so on, even those unbelievers such as yourselves. Think on that one!
Well, if he was going to die without the medicine, then obviously "god" was a failure. He lived because of the medicine, so I would think the R&D staff at Chimerix deserve the kudos.

What an insult to the people that worked on the drug by this woman.
If all the glory goes to god, then why was chimerix or its drug or the doctors or the nurses or the hospital necessary? I have a feeling there is a lot more praise to be distributed here.
page 1
sort order: oldest first | newest first

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Scroll